The Enhanced Importance of CD4 + T Cell Based Monitoring of Microbial Flora in Patients with HIV

Technical Summary: Enhanced Importance of CD4+ T Cell Based Monitoring of Microbial Flora in Patients with HIV

Problem Statement
Individuals infected with Human Immunodeficiency Virus (HIV) frequently suffer from diminished CD4+ T cell levels, leading to heightened susceptibility to diverse infections and significant clinical burdens. While the interaction between viral load, immune status, and microbial composition is recognized as vital for patient management, there is a need to better characterize the specific differences in lung microbial communities between general infections and HIV-associated cases. Conventional culture-based methods often fail to detect low-abundance or fastidious microorganisms, particularly in bronchoalveolar lavage fluid (BALF) where microbial loads can be low. This study addresses the gap in understanding how HIV infection and immune status (specifically CD4+ T cell counts) influence the bacterial and fungal landscape of the pulmonary microbiome.

Methodology
The study utilized a cohort of 221 patients admitted to Beijing Ditan Hospital between July and October 2019. Participants underwent bronchoscopy to collect 10 ml of BALF from the most affected lung segment. The cohort was stratified into four distinct groups based on HIV and Galactomannan (GM) test results:

1. HIV-negative, GM-negative (HNGN)
2. HIV-negative, GM-positive (HNGP)
3. HIV-positive, GM-negative (HPGN)
4. HIV-positive, GM-positive (HPGP)

Sequencing and Bioinformatics:

• Target Regions: Full-length 16S rDNA (bacteria) and Internal Transcribed Spacer (ITS) rDNA (fungi) regions were targeted.
• Extraction & Amplification: DNA was extracted using the MagNA Pure LC system. PCR amplification utilized specific primers (341F/805R for 16S) with Illumina adapter sequences and dual-index barcodes.
• Sequencing: Paired-end sequencing (250 bp × 2) was performed on the Illumina MiSeq platform.
• Data Processing: Quality filtering was conducted using USEARCH and FastQC. Operational Taxonomic Units (OTUs) were generated using an open-reference clustering strategy (Greengenes database for 16S; UNITE database for ITS) and de novo methods. OTUs were filtered to remove contaminants and low-abundance noise (thresholds of <10 reads for 16S and <1/1000 total reads for ITS).
• Statistical Analysis: Diversity indices were calculated using QIIME and DADA2. Principal Coordinate Analysis (PCoA) based on Bray-Curtis distance and PERMANOVA were used to assess community differences. Non-parametric tests (Wilcoxon and Kruskal-Wallis) were employed for group comparisons.

Key Results

• Clinical Demographics: The HIV-positive cohort (n=174) had a median CD4+ T cell count of 39 cells/µl, with 85% of patients exhibiting levels below 200 cells/µl, indicating poor immune status. Viral load showed a significant inverse correlation with CD4+ T cell counts.
• Microbial Diversity:
  • Fungal (ITS): GM-positive individuals (both HIV-negative and HIV-positive) displayed significantly increased fungal species diversity and a higher number of observed species compared to their GM-negative counterparts.
  • Bacterial (16S): Bacterial diversity indices and the number of observed species showed negligible overall variation across the groups.
• Microbial Composition:
  • Fungi: In GM-positive individuals, the relative abundance of Pneumocystidaceae (and Pneumocystis) decreased, while Aspergillaceae, Nectriaceae, Aspergillus, and Talaromyces increased. Notably, in HIV-positive patients with GM positivity, Pneumocystis abundance was higher compared to HIV-negative GM-positive patients, whereas Aspergillus and Candida showed reduced abundance in the HIV-positive group compared to the HIV-negative group.
  • Bacteria: GM-positive individuals showed reduced relative abundance of Prevotellaceae and Veillonellaceae, with increased abundance of Micrococcaceae, Staphylococcaceae, Pasteurellaceae, and Neisseriaceae.
• Immune-Microbiome Correlation:
  • In patients with poorer immune status (CD4+ < 200), Pneumocystis levels decreased, while Candida and Talaromyces levels increased. This trend was particularly pronounced in GM-positive patients.
  • Viral load was significantly higher in the "poor" immune status group compared to the "good" status group, regardless of GM status.

Significance and Claims
The paper asserts that 16S and ITS sequencing are indispensable tools for multidimensional analysis of the BALF microbiome, offering precise discrimination of bacterial and fungal signatures that conventional methods may miss. The study highlights that:

1. GM Testing and Fungal Diversity: GM test positivity is strongly associated with increased fungal diversity and specific shifts in fungal composition, rather than bacterial shifts.
2. Endogenous Pathogens: As infection progresses and immune status declines (low CD4+), endogenous fungi such as Candida and Talaromyces may become significant pathogens, shifting from symbiotic states to invasive infections.
3. Monitoring Necessity: The observed correlations between CD4+ T cell fluctuations, viral load dynamics, and microbial community shifts underscore the critical necessity for real-time monitoring of both immune status and microbial equilibrium in HIV-infected patients.

The authors conclude that integrating longitudinal monitoring of CD4+ T lymphocyte kinetics with microbial community stability analysis provides critical biomarkers for predicting opportunistic infection risks and guiding antimicrobial stewardship in HIV-associated pulmonary complications.